PATENT CLAIM ANALYSIS

Application Number: 16011723
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "411000"]

Abstract:
The present invention concerns a PTGDR-1 antagonist, a PTGDR-2 antagonist, a dual PTGDR-1/PTGDR-1 antagonist, or a combination of PTGDR-1 antagonist and PTGDR-2 antagonist, and pharmaceutical compositions containing them, for use for preventing and/or treating SLE.

Claim (Index 5):
The method according to  claim 1 , wherein said PTGDR-1 antagonist is used in combination with at least a PTGDR-2 antagonist.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 94.0
- Lexical Diversity: 1.57692
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15498202', '13989744', '15234754', '14192911', '14114733']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7373274140624048
- 35 USC 102 Novelty (BERT): 0.5431763922840591
- Combined Prediction Score: 0.7179123118845703
- Mean Citation Score: 261.078156
- Max Citation Score: 355.7615
- Similarity Product: 159.12436391142012

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test